Abstract 4591: Estrogen receptor-positive breast cancer: from genomic landscape to treatment approachPradip De, Brian Leyland‐Jones, Casey Williams et al.|Cancer Research|2016Cited by 1
P049 Genomic landscape of the PI3K pathway and cell-cycle pathway in ER+ BC: a treatment strategyPolev De, B Leyland-Jones, Christopher S. Williams et al.|The Breast|2015Cited by 0
HER2 amplification and overexpression between primary and liver metastatic breast cancer: Significance and implication.Casey Williams, Brian Leyland‐Jones, Pradip De et al.|Journal of Clinical Oncology|2014Cited by 0
Abstract B106: Algorithmic basis for combination of PI3K pathway isoform-specific inhibitors: Navigating the genomic landscape in ER+ breast cancersNandini Dey, Brian Leyland‐Jones, Casey Williams et al.|Molecular Cancer Therapeutics|2015Cited by 0
Abstract 1980: Identification of the transcription factor ZNF217 in ER+ subset of BC: A functional relationship with the PI3K-AKT-mTOR pathwayNandini Dey, Brian Leyland‐Jones, Casey Williams et al.|Cancer Research|2015Cited by 0